These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 16183221)
1. In vivo evaluation of nicotine lyophilised nasal insert in sheep. McInnes FJ; Thapa P; Baillie AJ; Welling PG; Watson DG; Gibson I; Nolan A; Stevens HN Int J Pharm; 2005 Nov; 304(1-2):72-82. PubMed ID: 16183221 [TBL] [Abstract][Full Text] [Related]
2. Nasal administration of metoclopramide from different dosage forms: in vitro, ex vivo, and in vivo evaluation. Tas C; Ozkan CK; Savaser A; Ozkan Y; Tasdemir U; Altunay H Drug Deliv; 2009 Apr; 16(3):167-75. PubMed ID: 19514977 [TBL] [Abstract][Full Text] [Related]
4. Nasal absorption of metoclopramide from different Carbopol 981 based formulations: In vitro, ex vivo and in vivo evaluation. Tas C; Ozkan CK; Savaser A; Ozkan Y; Tasdemir U; Altunay H Eur J Pharm Biopharm; 2006 Oct; 64(2):246-54. PubMed ID: 16870409 [TBL] [Abstract][Full Text] [Related]
5. The use of simple dynamic mucosal models and confocal microscopy for the evaluation of lyophilised nasal formulations. McInnes F; Baillie AJ; Stevens HN J Pharm Pharmacol; 2007 Jun; 59(6):759-67. PubMed ID: 17637168 [TBL] [Abstract][Full Text] [Related]
6. In vivo studies on nasal preparations of ciprofloxacin hydrochloride. Ozsoy Y; Tunçel T; Can A; Akev N; Birteksöz S; Gerçeker A Pharmazie; 2000 Aug; 55(8):607-9. PubMed ID: 10989839 [TBL] [Abstract][Full Text] [Related]
7. Characterisation of protein stability in rod-insert vaginal rings. Pattani A; Lowry D; Curran RM; McGrath S; Kett VL; Andrews GP; Malcolm RK Int J Pharm; 2012 Jul; 430(1-2):89-97. PubMed ID: 22486955 [TBL] [Abstract][Full Text] [Related]
8. Nasal administration of carbamazepine using chitosan microspheres: in vitro/in vivo studies. Gavini E; Hegge AB; Rassu G; Sanna V; Testa C; Pirisino G; Karlsen J; Giunchedi P Int J Pharm; 2006 Jan; 307(1):9-15. PubMed ID: 16257156 [TBL] [Abstract][Full Text] [Related]
9. Development and testing of particulate formulations for the nasal delivery of antibodies. Kaye RS; Purewal TS; Alpar OH J Control Release; 2009 Apr; 135(2):127-35. PubMed ID: 19059291 [TBL] [Abstract][Full Text] [Related]
10. Development of novel bioadhesive granisetron hydrochloride spanlastic gel and insert for brain targeting and study their effects on rats. Abdelmonem R; El Nabarawi M; Attia A Drug Deliv; 2018 Nov; 25(1):70-77. PubMed ID: 29228824 [TBL] [Abstract][Full Text] [Related]
11. Formulation and stability study of chlorpheniramine maleate nasal gel. Soliman II; Soliman NA; Abdou EM Pharm Dev Technol; 2010; 15(5):484-91. PubMed ID: 20735301 [TBL] [Abstract][Full Text] [Related]
12. Intranasal absorption of rizatriptan--in vivo pharmacokinetics and bioavailability study in humans. Chen J; Jiang XG; Jiang WM; Gao XL; Mei N Pharmazie; 2005 Jan; 60(1):39-41. PubMed ID: 15702515 [TBL] [Abstract][Full Text] [Related]
13. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. Zaki NM; Awad GA; Mortada ND; Abd Elhady SS Eur J Pharm Sci; 2007 Dec; 32(4-5):296-307. PubMed ID: 17920822 [TBL] [Abstract][Full Text] [Related]
15. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats. Khan S; Patil K; Bobade N; Yeole P; Gaikwad R J Drug Target; 2010 Apr; 18(3):223-34. PubMed ID: 20030503 [TBL] [Abstract][Full Text] [Related]
16. Development of a novel nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessation. Cheng YH; Watts P; Hinchcliffe M; Hotchkiss R; Nankervis R; Faraj NF; Smith A; Davis SS; Illum L J Control Release; 2002 Feb; 79(1-3):243-54. PubMed ID: 11853935 [TBL] [Abstract][Full Text] [Related]
17. Hydrophilic nasal gel of lidocaine hydrochloride. 2nd communication: Improved bioavailability and brain delivery in rats with low ciliotoxicity. Hu KL; Mei N; Feng L; Jiang XG Arzneimittelforschung; 2009; 59(12):635-40. PubMed ID: 20108649 [TBL] [Abstract][Full Text] [Related]
18. Intranasal delivery of recombinant human growth hormone (somatropin) in sheep using chitosan-based powder formulations. Cheng YH; Dyer AM; Jabbal-Gill I; Hinchcliffe M; Nankervis R; Smith A; Watts P Eur J Pharm Sci; 2005 Sep; 26(1):9-15. PubMed ID: 15970435 [TBL] [Abstract][Full Text] [Related]
19. Rapid-onset intranasal delivery of metoclopramide hydrochloride Part II: Safety of various absorption enhancers and pharmacokinetic evaluation. Zaki NM; Mortada ND; Awad GA; Abd ElHady SS Int J Pharm; 2006 Dec; 327(1-2):97-103. PubMed ID: 16959453 [TBL] [Abstract][Full Text] [Related]
20. Design and evaluation of oral bioadhesive controlled release formulations of miglitol, intended for prolonged inhibition of intestinal alpha-glucosidases and enhancement of plasma glucagon like peptide-1 levels. Deshpande MC; Venkateswarlu V; Babu RK; Trivedi RK Int J Pharm; 2009 Oct; 380(1-2):16-24. PubMed ID: 19563873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]